Director/PDMR Shareholding
21 July 2021 15:50 BST Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that on 21 July 2021, Marc Dunoyer, Chief Financial Officer, received 21,243 Ordinary Shares of $0.25 each in the Company (Ordinary Shares). The Ordinary Shares were issued to Mr Dunoyer on completion of the Company's acquisition of Alexion Pharmaceuticals, Inc. (Alexion) as part consideration for the 20,000 Alexion shares held by Mr Dunoyer at the time of completion. In accordance with the Agreement and Plan of Merger entered into by the Company on 12